-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Atlas Lithium Corporation (ATLX)

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Atlas Lithium Corporation (NASDAQ: ATLX) common stock between May 25, 2022 and May 3, 2023. Atlas Lithium, formerly known as Brazil Minerals, is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earths, graphite, and titanium.

For more information, submit a form, email Aaron Dumas, Jr., or give us a call (800) 350-6003.

What is this Case About: Atlas Lithium Corporation (ATLX) Misled Investors Regarding its Mining Capabilities and Conducted Deceptive Promotions to Inflate the Company's Stock

According to the complaint, throughout the class period, defendants failed to disclose that: (i) the Company overstated the success of its lithium mining and misrepresented the nature of its Brazilian mineral rights; (ii) in connection with these misrepresentations, Atlas Lithium conducted deceptive promotions to artificially inflate the value of the Company’s stock; (iii) the foregoing conduct was designed to allow CEO Fogassa and other Company insiders to sell shares back into the market for a profit before the true nature of Atlas Lithium’s business was revealed; and (iv) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

On May 4, 2023, Bleecker Street Research published a report entitled "Atlas Lithium (ATLX): First Comes The Pump … Now Here Comes the Dump." The report described Atlas Lithium as a “pretender” and stated that “it resembles many of the characteristics of a pump and dump.” The report alleged that Atlas Lithium’s “predecessor company did a similar promotion before bagging retail investors”; that “Atlas Lithium’s CEO was previously associated with Hunter Wise Securities, a broker fined $105 million for claiming to sell physical gold that it didn’t have”; and that “[EF Hutton, a] similarly disastrous bank[,] handled ATLX’s most recent offering and uplisting in early January.” On this news, Atlas Lithium’s stock price fell $12.95 per share, or 43.34%, to close at $16.93 per share on May 4, 2023.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Atlas Lithium Corporation. Shareholders who want to act as lead plaintiff for the class must file their papers by August 1, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Atlas Lithium Corporation. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:ATLX

Release Summary
Atlas Lithium Corporation (ATLX) Misled Investors Regarding its Mining Capabilities and Conducted Deceptive Promotions to Inflate its Stock
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

REGN Stock Drop: If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Leading the Class Action Lawsuit

SAN DIEGO, Calif.--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of investors who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”). The lawsuit alleges that Regeneron Pharmaceuticals misled investors regarding the viability and prospects of its Phase 3 Fianlimab-Libtayo clinical trial for patients with advanced melanoma. Invest...

Shareholder Alert - Robbins LLP Informs Investors of the Pentair plc Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Pentair plc (NYSE: PNR) securities between April 28, 2026 and July 14, 2026 (the "Class Period"). Pentair provides various water solutions, such as filtration, water supply pumps, and fluid treatment products. The lawsuit alleges that Pentair plc misled investors regarding the destocking of its inventory in the Pool ch...

Stockholder Alert: Robbins LLP Informs Investors of the Alibaba Group Holding Limited (BABA) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Alibaba Group Holding Limited (NYSE:BABA) between June 26, 2025 and June 24, 2026 (the "Class Period"). The complaint alleges that Alibaba failed to inform investors that it was considered a Chinese military company and that it was at risk of being impacted by the U.S.'s crackdown on Chinese military compani...
Back to Newsroom